Evaluation of the respective influence of thyroid hormones and TSH on blood coagulation parameters after total thyroidectomy

European Journal of Endocrinology

Volumn 164, Issue 4, 2011, Pages 599-603

  Yango, John ^a   Alexopoulou, Orsalia ^a   Eeckhoudt, Stephane ^a   Hermans, Cedric ^a   Daumerie, Chantal ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 8; COLLAGEN; FIBRINOGEN; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; THYROID HORMONE; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR ANTIGEN; RECOMBINANT HORMONE;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; EUTHYROIDISM; FEMALE; HUMAN; HYPOTHYROIDISM; INTERNATIONAL NORMALIZED RATIO; MALE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; THROMBIN TIME; THROMBOCYTE COUNT; THYROID CANCER; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; ADULT; BINDING ASSAY; BLEEDING TENDENCY; CLINICAL ASSESSMENT; COLLAGEN SYNTHESIS; DISEASE ASSOCIATION; DRUG EFFECT; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HORMONE SUBSTITUTION; MAJOR CLINICAL STUDY; MEDICAL HISTORY; THYROXINE BLOOD LEVEL;

ADULT; BLOOD COAGULATION; FEMALE; FIBRINOGEN; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THYROID HORMONES; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; THYROXINE;

EID: 79953200845     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0837     Document Type: Article

References (37)

1. Hoefbauer LC & Heufelder AE. Coagulation disorders in thyroid diseases. European Journal of Endocrinology 1997 136 1-7. (doi:10.1530/eje.0. 1360001)
2. Squizzato A, Romualdi E, Buller HR & Gerdes VEA. Thyroid dysfunction and effects on the coagulation and fibrinolysis: a systematic review. Journal of Clinical Endocrinology and Metabolism 2007 92 2415-2420. (doi:10.1210/jc.2007- 0199)
3. Franchini M, Montagnana M, Manzato F & Vescovi PP. Thyroid dysfunction and hemostasis: an issue still unresolved. Seminars in Thrombosis and Hemostasis 2009 35 288-294. (doi:10.1055/s-0029-1222607)
4. Franchini M. Hemostasis and thyroid diseases revisited. Journal of Endocrinological Investigation 2004 27 886-892. (Pubitemid 40305523)
5. Franchini M, Lippi G, Manazato F, Vescovi PP & Tagher G. Hemostatic abnormalities in endocrine and metabolic disorders. European Journal of Endocrinology 2010 162 439-451. (doi:10.1530/EJE-09-0958)
6. Myrup B, Bregengard C & Faber J. Primary haemostasis in thyroid disease. Journal of Internal Medicine 1995 238 59-63. (doi:10.1111/j.1365-2796. 1995.tb00899.x)
7. Ford HC & Carter JM. Haemostasis in hypothyroidism. Postgraduate Medical Journal 1990 66 280-284. (doi:10.1136/pgmj.66.774.280)
8. Dalton RG, Dewar MS, Savidge GF, Kernoof PB, Matthews KB & Preston FE. Hypothyroidism as a cause of acquired von Willebrand's disease. Lancet 1987 1 1007-1009. (doi:10.1016/S0140-6736(87)92272-0)
9. Manfredi E, Zaane BV, Gerdes VEA, Brandjes DPM & Squizzato A. Hypothyroidism and acquired von Willebrand syndrome: a systematic review. Haemophilia 2008 14 423-433. (doi:10.1111/j.1365-2516.2007.01642.x)
10. Franchini M, Zugni C, Veneri D, Gandini G, Lippi G, Manzato F & Brazzarola P. High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery. Haematologica 2004 89 1341-1346. (Pubitemid 39540571)
11. Michiels JJ, Bememan Z & Van der Planken M. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine. Clinical and Applied Thrombosis/Hemostasis 2001 7 113-115. (doi:10.1177/ 107602960100700206)
12. Muller B, Tsakiris DA, Roth CB, Guglielmetti M, Staub JJ & Marbet GA. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. European Journal of Clinical Investigation 2001 31 131-137. (doi:10.1046/j.1365-2362.2001.00777.x)
13. Homonncik M, Gessl A, Ferlitsch A, Jilma B & Vierhapper H. Altered platelet plug formation in hyperthyroidism and hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2007 92 3006-3012. (doi:10.1210/jc.2006- 2644)
14. Erem C. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clinical Endocrinology 2006 64 323-329. (doi:10.1111/j.1365-2265. 2006.02464.x)
15. Erem C, Ersoz HO, Karti Ss, Ukinc K, Hacihasanoglu A, Deger O & Telatar M. Blood coagulation and fibrinolysis in patients with hyperthyroidism. Journal of Endocrinological Investigation 2002 25 345-350. (Pubitemid 34436130)
16. Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A & Turpin G. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2001 86 732-737. (doi:10.1210/jc.86.2.732)
17. Chadarevian R, Bruckert E, Ankri A, Beucler I, Giral P & Turpin G. Relationship between thyroid hormones and plasma D-dimer levels. Thrombosis and Haemostasis 1998 79 99-103. (Pubitemid 28037066)
18. Gullu S, Sav H & Kamel N. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. European Journal of Endocrinology 2005 152 355-361. (doi:10.1530/eje.1.01857)
19. Chadarevian R, Jublanc C, Bruckert E, Giral P, Ankri A, Leenhardt L, Chapman J & Turpin G. Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidism. Journal of Endocrinological Investigation 2005 28 398-404. (Pubitemid 43162733)
20. Franchini M, Lippi G, Manzato F & Vescovi PP. Thyroid associated auto-immune coagulation disorders. Journal of Thrombosis and Thrombolysis 2009 28 362-365. (doi:10.1007/s11239-008-0253-7)
21. Meiklejohn DJ &Watson HG. Acquired haemophilia in association with organ-specific auto-immune disease. Haemophilia 2001 7 523-525. (doi:10.1046/j.1365-2516.2001.00519.x)
22. Debeij Jan, Suzanne CC, van Zaane Bregje, Smit Johannes WA, Corssmit Eleonore PM, Rosendaal Frits R, Romijn Johannes A & Dekkers Olaf M. The effect of changes in thyroxine and thyroid stimulating hormone levels on the coagulation system. Journal of Thrombosis and Haemostasis 2010 8 2823-2826. (doi:10.1111/j.1538-7836.2010.04054.x)
23. Liu Longbin, Wang Xiangbin, Lin Zhusan &Wu Hanwen. Elevated plasma levels of VWF:Ag in hyperthyroidism are mediated through beta-adrenergic receptors. Endocrine Research 1993 19 123-133. (doi:10.3109/07435809309033019)
24. Shih CH, Chen SL, Yan CC, Huang YH, Chen CD, Lee YS & Lin KH. Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 2004 145 2804-2814. (doi:10.1210/en.2003- 1372)
25. Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P, Mantzos J, Stamateloulous S & Koutras DA. Flow-mediated, endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 19977411-414. (doi:10.1089/thy.1997.7.411)
26. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Salvetti A, Ferrannini E & Monzani F. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. Journal of Clinical Endocrinology and Metabolism 2003 88 3731-3737. (doi:10.1210/jc.2003-030039)
27. Papaionnou GI, Lagasse M, Mather JF & Thompson PD. Treating hypothyroidism improves endothelium function. Metabolism 2004 53 278-279. (doi:10.1016/j.metabol.2003.10.003)
28. Cappola AR & Ladenson PW. Hypothyroidism and atherosclerosis. Journal of Clinical Endocrinology and Metabolism 2003 88 2438-2444. (doi:10.1210/jc.2003-030398)
29. Napoli R, Biondi B, Guardasole V, D'Anna C, DE Sena A, Pirozzi C, Terracciano D, Mazzarella C, Matarazzo M & Sacca L. Enhancement of vascular endothelial function by recombinant human thyrotropin. Journal of Clinical Endocrinology and Metabolism 2008 93 1959-1963. (doi:10.1210/jc.2007-2797)
30. Giusti M, Valenti S, Guazzino B, Molinari E, Cavallero D, Augeri C & Minuto A. Circulating nitric oxide is modulated by recombinant human TSH during monitoring of thyroid cancer remnant. Journal of Endocrinological Investigation 2003 26 1192-1197. (Pubitemid 38324736)
31. Dardano A, Ghiardoni L, Plantinga Y, Caraccio N, Bemi A, Duranti E, Taddei S, Ferrannini E, Salvetti A & Monzani F. Recombinant human thyrotropin reduces endothelium-dependent vasodilatation in patients monitored for differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 2006 91 4175-4178. (doi:10.1210/jc.2006-0440)
32. Borawski J, Nauminck B, Pawlak K & Mysliwiec M. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and acute phase response. Nephrology, Dialysis, Transplantation 2001 16 1442-1447. (doi:10.1093/ndt/16.7. 1442)
33. Horvath B, Hegedus D, Szapary L, Marton Z, Alexy T, Koltai K, Czopf L, Wittmann I, Jurcskay I, Kalman T & Kesmarky G. Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases. Experimental and Clinical Cardiology 2004 9 31-34. (Pubitemid 38765356)
34. Lip GY & Blann AD. von Willebrand factor and its relevance to cardiovascular disorders. British Heart Journal 1995 74 580-583. (doi:10.1136/hrt.74.6.580)
35. Franchini M, Capra F, Targher G, Montagnana M & Lippi G. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thrombosis Journal 2007 5 14. (doi:10.1186/1477-9560-5- 14)
36. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ & Montgomery RR. The effect of ABO group on the diagnosis of von Willebrand disease. Blood 1987 69 1691-1695. (Pubitemid 17091627)
37. Kumar S, Pruthi RK & Nichols William L. Acquired von Willebrand disease. Mayo Clinic Proceedings 2002 77 181-187. (doi:10.4065/77.2.181)